These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20544639)

  • 61. A case of active acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery.
    Okada Y; Morimoto I; Ejima K; Yoshida K; Kashimura M; Fujihira T; Eto S
    Endocr J; 1997 Feb; 44(1):117-20. PubMed ID: 9152623
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
    Campbell PG; Kenning E; Andrews DW; Yadla S; Rosen M; Evans JJ
    Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Determination of nadir growth hormone concentration cutoff in patients with acromegaly.
    Bancos I; Algeciras-Schimnich A; Woodmansee WW; Cullinane AK; Donato LJ; Nippoldt TB; Natt N; Erickson D
    Endocr Pract; 2013; 19(6):937-45. PubMed ID: 23807518
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical and biochemical improvement in acromegaly during pregnancy.
    Lau SL; McGrath S; Evain-Brion D; Smith R
    J Endocrinol Invest; 2008 Mar; 31(3):255-61. PubMed ID: 18401209
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Comparison between integrated 24-hour concentrations of growth hormone, insulin-like growth factor I and prolactin in acromegalic patients treated with octreotide and patients treated with octreotide LAR].
    Esposito V; Esposito D; Lo Iudice G
    Minerva Endocrinol; 2001 Dec; 26(4):289-92. PubMed ID: 11782718
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Kleine-Levin and Munchausen syndromes in a patient with recurrent acromegaly.
    Jungheim K; Badenhoop K; Ottmann OG; Usadel KH
    Eur J Endocrinol; 1999 Feb; 140(2):140-2. PubMed ID: 10069657
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
    Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
    Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome.
    Colao A; Pivonello R; Di Somma C; Tauchmanovà L; Savastano S; Lombardi G
    Clin Endocrinol (Oxf); 2007 May; 66(5):714-22. PubMed ID: 17388794
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Improvement of acromegaly after octreotide LAR treatment.
    Mangupli R; Lisette A; Ivett C; Paul C; de los Ríos Victoria C; Luis CJ
    Pituitary; 2003; 6(1):29-34. PubMed ID: 14674721
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The common consensus criteria have high predictive values for long-term postoperative acromegaly remission.
    Kristof RA; Grote A; Redel L; Neuloh G; Klingmüller D; Schramm J
    Acta Neurochir (Wien); 2011 Jan; 153(1):19-25. PubMed ID: 20845050
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly.
    Amato G; Mazziotti G; Rotondi M; Iorio S; Doga M; Sorvillo F; Manganella G; Di Salle F; Giustina A; Carella C
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):65-71. PubMed ID: 11849248
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials.
    Jimenez C; Burman P; Abs R; Clemmons DR; Drake WM; Hutson KR; Messig M; Thorner MO; Trainer PJ; Gagel RF
    Eur J Endocrinol; 2008 Nov; 159(5):517-23. PubMed ID: 18708436
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biochemical cure of acromegaly after transsphenoidal surgery despite residual tumor on magnetic resonance imaging: case report.
    Nishioka H; Haraoka J
    Neurol Med Chir (Tokyo); 2008 Jul; 48(7):311-3. PubMed ID: 18654051
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University.
    Fukuda I; Hizuka N; Murakami Y; Itoh E; Yasumoto K; Sata A; Takano K
    Intern Med; 2001 Oct; 40(10):987-92. PubMed ID: 11688841
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Desensitization to somatostatin analogue (Octreotide) observed in a patient with acromegaly.
    Haraguchi K; Ohtaka M; Takazawa K; Endo T; Onaya T
    Endocr J; 1995 Apr; 42(2):295-300. PubMed ID: 7627275
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential effects of octreotide treatment and transsphenoidal surgery on growth hormone-binding protein levels in patients with acromegaly.
    Hernandez I; Soderlund D; Espinosa-de-los-Monteros AL; Ochoa R; Zarate A; Mercado M
    J Neurosurg; 1999 Apr; 90(4):647-50. PubMed ID: 10193608
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [A Case of Acromegaly in which a Pituitary Gland Tumor was Reduced Significantly by Administering Octreotide Long Acting Release (LAR) and Could Be Removed Surgically].
    Arao T; Okada Y; Uemura F; Nishizawa S; Tanaka Y
    J UOEH; 2017; 39(3):241-245. PubMed ID: 28904276
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
    Bellut D; Hlavica M; Schmid C; Bernays RL
    Neurosurg Focus; 2010 Oct; 29(4):E9. PubMed ID: 20887134
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A case of juvenile acromegaly that was initially diagnosed as severe congestive heart failure from acromegaly-induced dilated cardiomyopathy.
    Sue M; Yoshihara A; Okubo Y; Ishikawa M; Ando Y; Hiroi N; Shibuya K; Yoshino G
    Intern Med; 2010; 49(19):2117-21. PubMed ID: 20930439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.